Loading clinical trials...
Loading clinical trials...
Effect of Intrathecal Transplant of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy
This study aimed to evaluate the therapeutic potential of human amniotic epithelial cell (hAEC) transplant in the management of children with spastic cerebral palsy.
Cerebral palsy is one of the most common congenital (existing at or before birth) disorders of childhood.Spastic cerebral palsy causes stiffness and movement difficulties.There is no cure for the disease now. This study aimed to evaluate the therapeutic potential of human amniotic epithelial cell (hAEC) transplant in the management of children with spastic cerebral palsy. hAEC will be intrathecal transplanted. Functional status is determined by Gross Motor Function Measure-66 and Fine Motor Function Measure. Spasticity is evaluated by using modified Ashworth scale(MAS).
Age
1 - 5 years
Sex
ALL
Healthy Volunteers
No
The Second Affiliated Hospital of Fujian Medical University
Quanzhou, Fujian, China
Start Date
April 1, 2017
Primary Completion Date
December 31, 2017
Completion Date
December 31, 2018
Last Updated
April 26, 2017
10
ESTIMATED participants
human amniotic epithelial cells
BIOLOGICAL
Lead Sponsor
The Second Affiliated Hospital of Fujian Medical University
Collaborators
NCT06598657
NCT05571033
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05126693